Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pipexus 0.26mg modified-release tablets
0409010W0BEAAAE
|
Pipexus | Pramipexole | Central Nervous System | 1,776 |
|
Pipexus 0.52mg modified-release tablets
0409010W0BEABAF
|
Pipexus | Pramipexole | Central Nervous System | 1,602 |
|
Pipexus 1.05mg modified-release tablets
0409010W0BEADAG
|
Pipexus | Pramipexole | Central Nervous System | 1,287 |
|
Pipexus 1.57mg modified-release tablets
0409010W0BEAEAJ
|
Pipexus | Pramipexole | Central Nervous System | 1,044 |
|
Pipexus 2.1mg modified-release tablets
0409010W0BEACAH
|
Pipexus | Pramipexole | Central Nervous System | 930 |
|
Pipexus 3.15mg modified-release tablets
0409010W0BEAGAI
|
Pipexus | Pramipexole | Central Nervous System | 608 |
|
Pipexus 2.62mg modified-release tablets
0409010W0BEAFAK
|
Pipexus | Pramipexole | Central Nervous System | 580 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.